# Sagaliam Acquisition Corp. (SAGA) Source: https://www.quantisnow.com/company/SAGA Generated: 2026-11-10T21:42:36.169Z - Ticker: SAGA - Exchange: NASDAQ - Sector: Finance - Industry: Blank Checks - IPO year: 2022 - Website: https://sagaliam.com ## About Sagaliam Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the telecommunications, media, and technology industries. The company was incorporated in 2021 and is based in Los Angeles, California. ## Latest SAGA news and filings - 2024-05-01 12:30 UTC [Sagaliam Acquisition Corp Launches Improved IPF Formula with Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-launches-improved-ipf-formula-with-vitamin-c-5447807) - 2024-04-26 12:00 UTC [Dividends] [Sagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-novation-agreement-with-enzolytics-inc-5435834) - 2024-04-09 14:30 UTC [SEC Form 25-NSE filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-sagaliam-acquisition-corp-5399982) - 2024-03-07 14:38 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-notice-of-delisting-5325823) - 2024-03-07 14:37 UTC [Market Chatter] [Sagaliam Acquisition To Delist From Nasdaq On March 6](https://www.quantisnow.com/insight/sagaliam-acquisition-to-delist-from-nasdaq-on-march-6-5325819) - 2024-03-07 14:35 UTC [SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-delisting-of-common-shares-from-nasdaq-5325812) - 2024-03-07 02:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sagaliam-acquisition-corp-5324729) - 2024-02-14 18:49 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Sagaliam Acquisition Corp. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-sagaliam-acquisition-corp-amendment-5261857) - 2024-02-14 17:16 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-sagaliam-acquisition-corp-5261412) - 2023-12-19 02:47 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sagaliam-acquisition-corp-5144762) - 2023-12-12 01:05 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-notice-of-delisting-5131402) - 2023-12-12 01:05 UTC [SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ DELISTING LETTER - UPDATED](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-receipt-of-nasdaq-delisting-letter---5131131) - 2023-12-11 22:17 UTC [Market Chatter] [Sagaliam Acquisition Corp. Receives Delisting Notification Letter From Nasdaq](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-receives-delisting-notification-letter-from-nasdaq-5130845) - 2023-12-11 22:15 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-notice-of-delisting-5130833) - 2023-12-11 22:16 UTC [SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ DELISTING LETTER](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-receipt-of-nasdaq-delisting-letter-5130829) - 2023-11-27 22:25 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-sagaliam-acquisition-corp-5104842) - 2023-11-20 22:28 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-notice-of-delisting-5096747) - 2023-11-20 22:15 UTC [SAGALIAM ACQUISITION CORP. ANNOUNCES A TEMPORARY RESTRAINING ORDER ON ITS EXTENSION PROXY SHAREHOLDER MEETING](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-a-temporary-restraining-order-on-its-5096659) - 2023-11-20 14:10 UTC [Dividends] [Enzolytics, Inc. Files Amended December 31, 2022 OTC Report with Audited Financials and Unaudited September 30, 2023 Quarterly Disclosure](https://www.quantisnow.com/insight/enzolytics-inc-files-amended-december-31-2022-otc-report-with-5095162) - 2023-10-20 21:21 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-sagaliam-acquisition-corp-5031154) - 2023-10-11 21:00 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-sagaliam-acquisition-corp-5015792) - 2023-09-18 12:15 UTC [Market Chatter] [Enzolytics Announces The Signing Of The Business Combination Agreement With Sagaliam Acquisition Corp](https://www.quantisnow.com/insight/enzolytics-announces-the-signing-of-the-business-combination-agreement-with-4974766) - 2023-09-18 12:00 UTC [Enzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)](https://www.quantisnow.com/insight/enzolytics-announces-the-signing-of-the-business-combination-agreement-with-4974709) - 2023-09-15 21:22 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-entry-into-a-4973956) - 2023-09-15 20:47 UTC [SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-execution-of-definitive-business-combination-agreement-4973757) - 2023-08-24 12:00 UTC [Biogenysis' International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.](https://www.quantisnow.com/insight/biogenysis-international-patent-application-covering-its-anti-sars-cov-2-monoclonal-antibodies-advances-4935986) - 2023-08-08 17:00 UTC [Virogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the Treatment](https://www.quantisnow.com/insight/virogentics-inc-receives-permit-for-export-to-africa-of-the-4862031) - 2023-08-08 13:29 UTC [Market Chatter] [Sagaliam Acquisition Confirms Funding And Extension Of Deadline To Complete Business Combination; Deposits $57,380.22 In Trust Account For Public Stockholders](https://www.quantisnow.com/insight/sagaliam-acquisition-confirms-funding-and-extension-of-deadline-to-complete-4860502) - 2023-08-08 13:25 UTC [SAGALIAM ACQUISITION CORP. CONFIRMS FUNDING AND EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-confirms-funding-and-extension-of-deadline-to-4860480) - 2023-08-08 13:22 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-other-events-financial-4860472) - 2023-07-28 21:15 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-leadership-update-4814444) - 2023-07-28 21:00 UTC [Leadership Update] [SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AND APPOINTMENT OF INDEPENDENT DIRECTORS](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-receipt-of-nasdaq-listing-delinquency-letter-4814230) - 2023-07-11 14:05 UTC [Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/enzolytics-inc-files-supplemental-information-report-on-the-sale-of-4740579) - 2023-07-06 15:45 UTC [Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical Trials](https://www.quantisnow.com/insight/virogentics-inc-to-introduce-a-dietary-supplement-offers-additional-information-4726035) - 2023-06-30 13:28 UTC [Market Insight] [Sagaliam Acquisition Corp. Announces Amendment To Non-Binding Term Sheet With Enzolytics Inc., Amending The Combined Purchase Price To $450M And Addition Of New Board Members](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-amendment-to-non-binding-term-sheet-with-4707823) - 2023-06-30 13:15 UTC [Sagaliam Acquisition Corp. Announces Amendment to Non-Binding Term Sheet with Enzolytics Inc. and Addition of New Board Members](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-announces-amendment-to-non-binding-term-sheet-with-4707752) - 2023-06-29 16:22 UTC [SAGALIAM ACQUISITION CORP. CONFIRMS FUNDING AND EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-confirms-funding-and-extension-of-deadline-to-4702912) - 2023-06-29 16:05 UTC [SEC Form 8-K] [Sagaliam Acquisition Corp. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/sagaliam-acquisition-corp-filed-sec-form-8-k-leadership-update-other-4702811) - 2023-06-29 13:30 UTC [Public Offering] [Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/enzolytics-inc-reports-amendment-to-non-binding-term-sheet-with-the-4701555) - 2023-06-02 17:55 UTC [SEC Form 8-K] [SEC Form 8-K filed by Sagaliam Acquisition Corp.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-sagaliam-acquisition-corp-4595960) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SAGA - Earnings history: https://www.quantisnow.com/earnings/SAGA - Dividend history: https://www.quantisnow.com/dividends/SAGA - Insider transactions: https://www.quantisnow.com/insiders/SAGA - Options chain: https://www.quantisnow.com/options/SAGA - SEC 8-K filings only: https://www.quantisnow.com/company/SAGA/8-k - RSS and alerts for SAGA: https://www.quantisnow.com/docs/rss-feeds.md